Literature DB >> 10966406

Production of angiotensin-I-converting-enzyme-inhibitory peptides in fermented milks started by Lactobacillus delbrueckii subsp. bulgaricus SS1 and Lactococcus lactis subsp. cremoris FT4.

M Gobbetti1, P Ferranti, E Smacchi, F Goffredi, F Addeo.   

Abstract

Two fermented milks containing angiotensin-I-converting-enzyme (ACE)-inhibitory peptides were produced by using selected Lactobacillus delbrueckii subsp. bulgaricus SS1 and L. lactis subsp. cremoris FT4. The pH 4.6-soluble nitrogen fraction of the two fermented milks was fractionated by reversed-phase fast-protein liquid chromatography. The fractions which showed the highest ACE-inhibitory indexes were further purified, and the related peptides were sequenced by tandem fast atom bombardment-mass spectrometry. The most inhibitory fractions of the milk fermented by L. delbrueckii subsp. bulgaricus SS1 contained the sequences of beta-casein (beta-CN) fragment 6-14 (f6-14), f7-14, f73-82, f74-82, and f75-82. Those from the milk fermented by L. lactis subsp. cremoris FT4 contained the sequences of beta-CN f7-14, f47-52, and f169-175 and kappa-CN f155-160 and f152-160. Most of these sequences had features in common with other ACE-inhibitory peptides reported in the literature. In particular, the beta-CN f47-52 sequence had high homology with that of angiotensin-II. Some of these peptides were chemically synthesized. The 50% inhibitory concentrations (IC(50)s) of the crude purified fractions containing the peptide mixture were very low (8.0 to 11.2 mg/liter). When the synthesized peptides were used individually, the ACE-inhibitory activity was confirmed but the IC(50)s increased considerably. A strengthened inhibitory effect of the peptide mixtures with respect to the activity of individual peptides was presumed. Once generated, the inhibitory peptides were resistant to further proteolysis either during dairy processing or by trypsin and chymotrypsin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10966406      PMCID: PMC92236          DOI: 10.1128/AEM.66.9.3898-3904.2000

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  22 in total

Review 1.  Bioactive peptides encrypted in milk proteins: proteolytic activation and thropho-functional properties.

Authors:  H Meisel; W Bockelmann
Journal:  Antonie Van Leeuwenhoek       Date:  1999 Jul-Nov       Impact factor: 2.271

2.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

4.  Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure, and synthesis.

Authors:  M A Ondetti; N J Williams; E F Sabo; J Pluscec; E R Weaver; O Kocy
Journal:  Biochemistry       Date:  1971-10-26       Impact factor: 3.162

5.  Proteinases in normal bovine milk and their action on caseins.

Authors:  A T Andrews
Journal:  J Dairy Res       Date:  1983-02       Impact factor: 1.904

Review 6.  Enzymes of the renin-angiotensin system and their inhibitors.

Authors:  M A Ondetti; D W Cushman
Journal:  Annu Rev Biochem       Date:  1982       Impact factor: 23.643

Review 7.  Caseins of various origins and biologically active casein peptides and oligosaccharides: structural and physiological aspects.

Authors:  A M Fiat; P Jollès
Journal:  Mol Cell Biochem       Date:  1989-05-04       Impact factor: 3.396

8.  Angiotensin I converting enzyme in human intestine and kidney. Ultrastructural immunohistochemical localization.

Authors:  P Bruneval; N Hinglais; F Alhenc-Gelas; V Tricottet; P Corvol; J Menard; J P Camilleri; J Bariety
Journal:  Histochemistry       Date:  1986

9.  Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790.

Authors:  N Yamamoto; A Akino; T Takano
Journal:  J Dairy Sci       Date:  1994-04       Impact factor: 4.034

Review 10.  Franz Volhard Lecture. Renin-angiotensin system: a dual tissue and hormonal system for cardiovascular control.

Authors:  C I Johnston
Journal:  J Hypertens Suppl       Date:  1992-12
View more
  29 in total

1.  Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients.

Authors:  Raffaella Di Cagno; Maria De Angelis; Salvatore Auricchio; Luigi Greco; Charmaine Clarke; Massimo De Vincenzi; Claudio Giovannini; Massimo D'Archivio; Francesca Landolfo; Giampaolo Parrilli; Fabio Minervini; Elke Arendt; Marco Gobbetti
Journal:  Appl Environ Microbiol       Date:  2004-02       Impact factor: 4.792

2.  Alkaline protease gene cloning from the marine yeast Aureobasidium pullulans HN2-3 and the protease surface display on Yarrowia lipolytica for bioactive peptide production.

Authors:  Xiumei Ni; Lixi Yue; Zhenming Chi; Jing Li; Xianghong Wang; Catherine Madzak
Journal:  Mar Biotechnol (NY)       Date:  2008-07-15       Impact factor: 3.619

3.  Oyster (Crassostrea gigas) hydrolysates produced on a plant scale have antitumor activity and immunostimulating effects in BALB/c mice.

Authors:  Yu-Kai Wang; Hai-Lun He; Guo-Fan Wang; Hao Wu; Bai-Cheng Zhou; Xiu-Lan Chen; Yu-Zhong Zhang
Journal:  Mar Drugs       Date:  2010-02-02       Impact factor: 5.118

4.  Casein fermentate of Lactobacillus animalis DPC6134 contains a range of novel propeptide angiotensin-converting enzyme inhibitors.

Authors:  M Hayes; C Stanton; H Slattery; O O'Sullivan; C Hill; G F Fitzgerald; R P Ross
Journal:  Appl Environ Microbiol       Date:  2007-05-04       Impact factor: 4.792

5.  Casein-derived antimicrobial peptides generated by Lactobacillus acidophilus DPC6026.

Authors:  M Hayes; R P Ross; G F Fitzgerald; C Hill; C Stanton
Journal:  Appl Environ Microbiol       Date:  2006-03       Impact factor: 4.792

6.  Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats.

Authors:  Anders Fuglsang; Dan Nilsson; Niels C B Nyborg
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

7.  Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species.

Authors:  F Minervini; F Algaron; C G Rizzello; P F Fox; V Monnet; M Gobbetti
Journal:  Appl Environ Microbiol       Date:  2003-09       Impact factor: 4.792

8.  Purification and characterization of an alkaline protease from the marine yeast Aureobasidium pullulans for bioactive peptide production from different sources.

Authors:  Chunling Ma; Xiumei Ni; Zhenming Chi; Liyan Ma; Lingmei Gao
Journal:  Mar Biotechnol (NY)       Date:  2007-03-07       Impact factor: 3.619

Review 9.  Theoretical benefits of yogurt-derived bioactive peptides and probiotics in COVID-19 patients - A narrative review and hypotheses.

Authors:  Ahmed S Gouda; Fatima G Adbelruhman; Hamedah Sabbah Alenezi; Bruno Mégarbane
Journal:  Saudi J Biol Sci       Date:  2021-06-18       Impact factor: 4.052

10.  Health-Promoting Properties of Lactobacillus helveticus.

Authors:  Valentina Taverniti; Simone Guglielmetti
Journal:  Front Microbiol       Date:  2012-11-19       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.